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Abstract
Prior to hibernation, the brown bear (Ursus arctos) exhibits unparalleled
weight gain. Unlike humans, weight gain in bears is associated with lower
levels of circulating free fatty acids (FFA) and increased insulin sensitivity.
Understanding how free-ranging brown bears suppress lipolysis when gaining
weight may therefore provide novel insight toward the development of human
therapies. Blood and subcutaneous adipose tissue were collected from immo-
bilized free-ranging brown bears (fitted with GPS-collars) during hibernation
in winter and from the same bears during the active period in summer in
Dalarna, Sweden. The expression of lipid droplet-associated proteins in adi-
pose tissue was examined under the hypothesis that bears suppress lipolysis
during summer while gaining weight by increased expression of negative regu-
lators of lipolysis. Adipose triglyceride lipase (ATGL) expression did not differ
between seasons, but in contrast, the expression of ATGL coactivator Compar-
ative gene identification-58 (CGI-58) was lower in summer. In addition, the
expression of the negative regulators of lipolysis, G0S2 and cell-death inducing
DNA fragmentation factor-a-like effector (CIDE)C markedly increased during
summer. Free-ranging brown bears display potent upregulation of inhibitors
of lipolysis in adipose tissue during summer. This is a potential mechanism
for increased insulin sensitivity during weight gain and G0S2 may serve as a
target to modulate insulin sensitivity.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
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Introduction
The current global pandemic of obesity and associated
diseases pose a major challenge for the wellbeing of the
affected individuals and for health care providers. Obesity
is closely associated with insulin resistance and this condi-
tion is a fundamental aspect of the etiology of type 2 dia-
betes (Kahn and Flier 2000). Insulin resistance precedes
the onset of diabetes by 1–2 decades (Warram et al.
1990) and lifestyle interventions that increase insulin sen-
sitivity prevent the onset of diabetes in high-risk popula-
tions (Pan et al. 1997; Tuomilehto et al. 2001; Knowler
et al. 2002). However, few pharmacologic approaches to
increase insulin sensitivity have been successful and novel
strategies are needed and inspiration for such may come
from observing hibernating brown bears (Ursus arctos).
During winter these animals are physical inactive and
bradycardic but do not develop vascular or heart disease.
Unlike most other hibernators, brown bears only reduce
body temperature marginally during hibernation. Data
suggest that bears have developed mechanisms for healthy
weight gain. Prior to hibernation, the brown bear exhibits
hyperphagia and weight gain unparalleled by humans
(Swenson et al. 2007). However, unlike what is observed
is humans, weight gain in brown bears is associated with
lower levels of free fatty acids (FFA) (Graesli et al. 2015).
By investigating brown bears living in captivity it has
been shown that insulin sensitivity is increased prior to
hibernation (Professor L. Nelson, pers. comm. 2016,
Washington State University, USA). FFAs are released by
hydrolysis of triglycerides in adipose tissue during lipoly-
sis and inappropriate stimulation of lipolysis, as seen with
obesity, has been suggested to play a major role in the
underlying pathophysiology of type 2 diabetes (Boden
and Shulman 2002). Understanding how brown bears
suppress lipolysis during summer when gaining weight
may therefore provide valuable insight toward the devel-
opment of human therapies.
In the adipocyte triglycerides are hydrolyzed to free
fatty acids (FFA) and glycerol by the sequential action of
Adipose Triglyceride Lipase (ATGL), Hormone Sensitive
Lipase (HSL) and Monoglyceride Lipase. ATGL catalyzes
the rate limiting step in lipolysis (Zimmermann et al.
2004), and the enzyme activity is tightly regulated by
complex formation between ATGL and several lipid dro-
plet-associated proteins. ATGL activity is acutely
increased via interaction with the coactivator comparative
gene identification-58 (CGI-58) (Lass et al. 2006). In the
basal state, CGI-58 is complexed with lipid-droplet-coat-
ing protein perilipin 1 (PLIN1) and ATGL activity is low.
Upon stimulation of lipolysis, for example, through
adrenergic receptor signaling, PLIN1 is phosphorylated
(Greenberg et al. 1991) and this promotes the release of
CGI-58 which binds to, and activates ATGL. The degree
of stimulation of ATGL activity by CGI-58 can be modu-
lated by binding of the protein product of G0/G1 switch
gene 2 (G0S2) to ATGL (Yang et al. 2010). Binding of
G0S2 to ATGL appears to be dominant to activation by
CGI-58 (Yang et al. 2010) and the inhibition of ATGL by
G0S2 is dose-dependent (Schweiger et al. 2012). There is
also evidence to suggest that the proapoptotic protein
family termed cell-death inducing DNA fragmentation
factor-a-like effector (CIDE) may regulate ATGL activity.
Two CIDE proteins, CIDE-A and CIDE-C, act as negative
regulators of lipolysis, most likely by shielding of the lipid
droplets from the action of lipases (Nordstrom et al.
2005; Puri et al. 2008) or by direct binding to ATGL
(Grahn et al. 2014).
The aim of this study was to investigate the expression
of lipid droplet associated proteins in adipose tissue from
free-ranging brown bears during hibernation in winter
and during their active period in summer. The underlying
hypothesis is that brown bears suppress lipolysis during
summer when gaining weight by increased expression of
negative regulators of ATGL activity.
Materials and Methods
Animal capture and biopsy procedure
Blood and subcutaneous adipose tissue were collected
from immobilized free-ranging brown bears (fitted with
GPS-collars) during hibernation in winter (early Febru-
ary) and, from the same bears, during the active period
in early summer (late June/early July) in Dalarna, Sweden.
All captures were approved by the Swedish Ethical Com-
mittee on Animal Research (C212/9 and C47/9) and the
Swedish Environmental Protection Agency and follow the
general principles of Public Health Service Policy on
Humane Care and Use of Laboratory Animals applicable
to wildlife. Sampling was done by the Scandinavian
Brown Bear Research Project (http://www.bearpro-
ject.info/) according to established protocols (Arnemo
et al. 2012).
Blood analysis
Serum FFAs were analyzed with a commercially available
kit (intraassay CV 2–4% and interassay CV 3–6%, detec-
tion limit 0.02 mmol/L) (NEFA-HR 2; Wako Chemicals,
Richmond, VA).
Histology
Adipose tissue biopsies were fixed in 4% formalin buffer
(Cellpath, Newtown, UK) and embedded in paraffin.
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3 lm sections were heated at 60°C for 60 min, deparaf-
finized in Tissue-Clear (Sakura Finetek Europe, Alphan,
the Netherlands) and rehydrated.
Western blot analysis
Adipose biopsies (~100 mg) were homogenized in a Pre-
cellys 24 homogenizer (Bertin Technologies, Montigny-le-
Bretonneux, France) in a hypotonic buffer containing
20 mmol/L HEPES pH 7.4, 10 mmol/L NaF, 1 mmol/L
Na3VO4, 1 mmol/L EDTA, 5% SDS, 50 lg/mL Soybean
Trypsin Inhibitor, 4 lg/mL Leupeptin, 0.1 mmol/L Ben-
zamidine, 2 lg/mL Antipain, and 1 lg/mL Pepstatin.
Crude homogenates were incubated in a Thermomixer
(Eppendorf, Hamburg, Germany) at 37°C and 1000 rpm
for 1 h followed by centrifugation at 14.000 9 g for
20 min. The lipid-free infranatant was aspirated and used
for western blot analysis.
Protein samples were resolved by SDS-PAGE (4–12%
Bis-Tris gels, Criterion XT system; Bio-Rad, Hercules, CA)
and transferred to polyvinylidene fluoride membranes
according to manufacturer’s instructions. The following
primary antibodies were used: anti-ATGL, anti-CGI-58
(Abcam, Cambridge, UK), anti-PLIN1, anti-HSL (Cell Sig-
naling, Beverly, MA), anti-CIDE-C (Novus Biologicals,
Cambridge, UK), and anti-G0S2, anti-uncoupling protein 1
(Santa Cruz Biotechnology; Santa Cruz, CA). Horseradish
peroxidase-conjugated donkey anti-rabbit IgG (Amersham,
GE-Healthcare, Pittsburgh, PA) and goat anti-mouse HRP-
IgG (Abcam, Cambridge, UK) were used as secondary anti-
bodies. Proteins were visualized by chemiluminescence
(Pierce Supersignal West Dura, Thermo Scientific, IL) and
quantified with the ChemiDocTM MP imaging system
(BioRad). Precision Plus All Blue protein standards were
used as a marker of molecular weight (BioRad). Control
for protein loading was performed using the Stain-Free
technology (Gurtler et al. 2013), and data are expressed as
a ratio to total protein content in the membranes.
Statistics
Normal distribution was tested by evaluation of QQ-plots
and histograms. When possible, nonparametric data were
transformed to a normal distribution by means of a loga-
rithmic transformation. Differences in G0S2 expression
were evaluated using Fisher’s exact test. Data are pre-
sented as mean  SEM unless otherwise stated. Statistical
analysis was performed by comparing hibernating and
nonhibernating conditions within the same bear (paired
t-test) and P < 0.05 was regarded as statistically signifi-
cant. Data were analyzed and graphs were designed in
SigmaPlot (SigmaPlot 11.0, Systat Software, CA).
Results
Animal characteristics
The basic characteristics of the animals are summarized
in Table 1. The bears gained weight between the two
sampling periods, but the increase was only borderline
significant (P < 0.08).
Table 1. Animals characteristics from five bears captured during
winter and summer 2013.
Summer Winter
Males/females 2/3 2/3
Age (years) 3 3
Weight (kg) 58 (38–64.5) 53 (40–55)*
Weight is expressed as median and range (*P < 0.08 vs. summer).
B
A
Figure 1. Hematoxylin and eosin staining of adipose tissue biopsies
taken from the inguinal fat pad from the same immobilized free-
ranging brown bear (fitted with GPS-collars) during summer (A) and
during hibernation in winter (B) from Dalarna, Sweden.
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Adipose tissue morphology
As shown in Figure 1, adipocyte cell size was smaller dur-
ing summer captures (A) than winter (B). Classical char-
acteristics of white adipose tissue with monovacuolar cells
containing a large lipid droplet surrounded by a layer of
cytoplasm could be recognized during both seasons. As
expected, we did not observe plurivacuolar cells character-
istic of brown fat in any biopsies and no expression of
uncoupling protein 1 was detected in the biopsies (data
not shown).
Blood samples
Circulating levels of FFA varied greatly among bears.
Mean level during summer was 0.20 mmol/L (0.08) and
0.43 mmol/L (0.09) during winter, but the differences
did not reach statistical significance.
Inhibitors of lipolysis is increased in the
nonhibernating condition
The expression of the prolipolytic cofactor CGI-58 was
during winter ~300% compared to summer levels
(P < 0.05) (Fig. 2A). The expression of the adipocyte-
specific lipid-coating protein PLIN1 was detected in both
hibernating and nonhibernating conditions with lower
expression levels in the adipose tissue taken during the
summer compared to winter biopsies (Fig. 2B). Adipose
tissue expression of the lipases ATGL and HSL (Fig. 2C
and D) did not change during seasons.
The expression of the negative regulators of lipolysis,
G0S2 and CIDE-C is depicted in Figure 3A and B. We
found decreased expression of CIDE-C (~50%) during
winter (P < 0.01), whereas the expression of G0S2 was
completely absent in adipose tissue from hibernating
bears (P < 0.01).
Discussion
By exploring the amazing adaptation for hibernation in
free-ranging brown bears we have found evidence for a
molecular mechanism that can contribute to explaining
the paradox of increased insulin sensitivity during weight
gain that is observed in brown bears living in captivity.
We suggest that the profound upregulation of inhibitors
of lipolysis during summer inhibits release of FFA to the
circulation during conditions characterized by a positive
energy balance (Swenson et al. 2007). The inhibitory
effects of elevating plasma FFA levels on peripheral
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Figure 2. (A–B) Protein content of the prolipolytic cofactor CGI-58 in adipose tissue biopsies during summer and winter (*P < 0.05 vs.
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insulin-stimulated glucose uptake and oxidation are well-
established (Belfort et al. 2005; Gormsen et al. 2007; Hoeg
et al. 2011), and the dynamic regulation of lipid-droplet-
coating proteins in brown bears adds evidence to the cen-
tral role of the adipocyte in control of whole body meta-
bolism.
Several lines of evidence demonstrate that alterations in
the expression of lipid-droplet-coating proteins play a
prominent role in regulation of lipolysis. Ablation of
G0S2 and CIDE-C in rodents increases lipolytic rates in
adipocytes (Nishino et al. 2008; Zhang et al. 2014). Under
physiological conditions, prolonged fasting decreases the
expression of G0S2 in humans and this is associated with
a reduced insulin-stimulated suppression of lipolysis
(Nielsen et al. 2011). Similar observations have been
made in fasting chicken, quails, and pigs (Oh et al. 2011;
Ahn et al. 2013). This demonstrates that the mechanism
is preserved among species, but the dramatic increase in
the expression of G0S2 in brown bears during summer
supersedes previously observed levels of regulation. Over-
expression of ATGL in mice increases lipolytic activity
(Ahmadian et al. 2009), but the inhibitory effects of G0S2
and CIDE-C during summer was not compensated by ele-
vations in ATGL expression. In fact, ATGL is only lipoly-
tic active when associated with CGI-58, and the increased
lipolytic activity in ATGL overexpressing mice is associ-
ated with a 3.5-fold increased level of CGI-58 (Ahmadian
et al. 2009). We found that CGI-58 was markedly
increased during hibernation and it is therefore likely that
the substantial upregulation of the lipolytic inhibitors
G0S2 and CIDE-C in summer was potentiated by down-
regulation of CGI-58 expression.
The expression levels of lipid-coating proteins are likely
to have clinical impact for patients with type 2 diabetes.
CIDE-C expression is reduced in obese subjects on a very
low calorie diet (Magnusson et al. 2008), and this will
likely contribute to weight loss and ultimately an
improvement in metabolic regulation. However, reduced
expression of inhibitors of lipolysis can also have negative
clinical consequences. Poor glycemic control in diabetic
patients is associated with reduced G0S2 expression in
adipose tissue and elevated circulating FFA levels (Nielsen
et al. 2012). This can initiate a viscous cycle with
increased insulin resistance in skeletal muscle and further
dysregulation of glycemic control (Boden and Shulman
2002). In humans, treatment with thiazolidinediones inhi-
bits lipolysis and this is associated with increased insulin
sensitivity and a favorable endocrine activity of adipose
tissue (DeFronzo 2009). However, due to undesirable off-
target effects of thiazolidinediones this treatment is not
recommended for most diabetics, and other strategies to
inhibit lipolysis are warranted. Compounds that mimic
the inhibitory action of CIDES and G0S2 could therefore
be of clinical relevance. It is therefore interesting that a
recent study has demonstrated that a synthetic peptide
corresponding to a short sequence of G0S2 can inhibit
ATGL activity in the nanomolar range (Cerk et al. 2014).
If such compounds can be utilized in a clinical setting, it
may be possible for humans to mimic some of the meta-
bolic adaptations observed in brown bears.
Studying free-ranging wildlife poses obvious limits for
which measurements are feasible to perform. Investigating
the bears in late summer during hyperphagic conditions
is not feasible as this can interrupt the animals prepara-
tion to hibernating phase. We did investigate lipolytic sig-
naling to hormone sensitive lipase, but observed great
variation among samples. This is likely an artifact
explained by differences in conditions of the individual
captures resulting in variable catecholamine levels.
Although less pronounced, we also observed variation in
circulating FFA levels between bears and this measure-
ment may also be influenced by the captures. However,
the seasonal levels we measured in free-ranging brown
bears correspond to observations in brown bears living in
captivity (Professor Lynne Nelson, Washington State
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Figure 3. (A) Expression of CIDE-C expressed as a ratio of total
protein content in the biopsy (†P < 0.01 vs. summer, N = 5). (B)
The expression of the negative regulator of lipolysis G0S2 was
completely ablated during hibernating conditions (N.D., Not
Detected; AU, Arbitrary units; †P < 0.01, N = 5).
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University USA, personal communication), and the fact
that the seasonal difference in FFA levels did not reach
statistical significance is due to low statistical power. A
previous report on seasonal changes in serum chemistry
in a larger group of free-living bears found significant dif-
ferences between winter and summer, but not between
winter and spring (Graesli et al. 2015). Unlike cate-
cholamine signaling and FFA levels, the expression levels
of lipid-coating proteins are unlikely to be significantly
affected by the conditions of the capture because the
bears are usually anesthetized within minutes, and
although the half-life of G0S2 is short (<1 h [Yang et al.
2011]), it is unlikely that protein expression levels change
over such short time frame.
In conclusion, free-ranging brown bears display potent
upregulation of inhibitors of lipolysis in adipose tissue
during summer. This may serve as an underlying mecha-
nism for the increased insulin sensitivity during weight
gain previously observed in bears living in captivity.
Accordingly, G0S2 may serve as a target to modulate
whole body glucose homeostasis.
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